Literature DB >> 1347714

Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells.

I Neumann1, D Thierau, U Andrae, H Greim, L R Schwarz.   

Abstract

The synthetic anti-androgen and progestin cyproterone acetate (CPA) is known to increase the liver tumor rate in rats. The tumorigenicity of CPA has been attributed to a tumor-promoting activity of the steroid. In order to discover whether CPA acts directly on preneoplastic liver cells or via indirect effects, we investigated whether CPA stimulates replicative DNA synthesis in vitro in hepatocytes isolated from carcinogen-treated rats (two-thirds hepatectomy, 1 x 30 mg diethylnitrosamine per kg and 0.1% phenobarbital in the drinking water) and whether the degree of stimulation differs in gamma-glutamyltranspeptidase (GGT)-positive, putatively preneoplastic and GGT-negative, 'normal' hepatocytes. The possibility that CPA might also have initiating potential was investigated by studying its effects on DNA repair synthesis. Stimulation of [3H]thymidine incorporation into the DNA by CPA was only observed in the presence of epidermal growth factor (EGF) (10 ng/ml) and insulin (10 mU/ml). Maximal effects were obtained between 2 and 10 microM. DNA synthesis in the presence of EGF/insulin was reduced by the 'pure' anti-androgen flutamide, but stimulated by the 'pure' progestin promegestone. In the presence of CPA, EGF and insulin, the labelling index was twice as high in GGT-positive as in GGT-negative liver cells, regardless of whether mitogens were added at 48 or 72 h. The labelling index did not differ in the GGT-positive and negative hepatocytes when CPA was omitted. These findings are consistent with the idea that CPA has tumor-promoting activity. CPA significantly induced repair synthesis in the isolated hepatocytes from both untreated and carcinogen-treated rats. This increase was detected at a concentration as low as 2 microM and maximal effects were obtained at 20 microM. These results indicate that CPA is not only a tumor-promoting, but also a genotoxic chemical, i.e. that it might also have an initiating potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347714     DOI: 10.1093/carcin/13.3.373

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

Review 1.  Cyproterone acetate: is it hepato- or genotoxic?

Authors:  T Rabe; K Feldmann; L Heinemann; B Runnebaum
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 2.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

Review 3.  Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

Authors:  R L Melnick; M C Kohn; C J Portier
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

4.  Coercion, incarceration, and chemical castration: an argument from autonomy.

Authors:  Thomas Douglas; Pieter Bonte; Farah Focquaert; Katrien Devolder; Sigrid Sterckx
Journal:  J Bioeth Inq       Date:  2013-06-29       Impact factor: 1.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.